Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Balçova
Clinical trial register · Turkey

Clinical Trials in Balçova, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Balçova

14 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Yenimahalle, Balçova, Adana, Ankara
2024-11-03
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Adana, Sakarya, Ankara, Kadıköy, Istanbul, Balçova, İzmit, Konya
2024-09-27
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Ankara, Balçova
2024-08-07
Active, closed
Umecrine Cognition AB
Phase 1/2
202
Ankara, Balçova, Diyarbakır, Izmir, Kocaeli, Rize, Sanliurfa, Trabzon
2023-04-14
Active, closed
Eli Lilly and Company
Phase 3
15,374
Adana, Ankara, Antalya, Aydin, Balçova, Bornova, Denizli, Gaziantep
2022-10-11
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
Loxo Oncology, Inc.
Phase 3
737
Ankara, Balçova, Bornova, Faith, Istanbul, Mamak
2022-07-22
Active, closed
Celgene
Phase 3
939
Kavaklıdere, Yenimahalle, Pendik, Balçova, Bornova, Samsun, Ankara, Gaziantep
2022-06-23
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Balçova, Kayseri, Sakarya, Samsun
2021-09-13
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Adana, Ankara, Balçova, Fatih, Gaziantep, Istanbul, Izmir, Malatya
2020-12-07
Active, closed
Acerta Pharma BV
Phase 3
611
Ankara, Balçova, Edirne, Izmir, Kayseri, Mersin, Samsun, Trabzon
2020-10-08
Active, closed
Stichting European Myeloma Network
Phase 2
41
Ankara, Balçova, Kayseri, Pendik
2019-10-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Üsküdar /Istanbul, Balçova, Adana, Ankara, Antalya, Edirne, Erzurum, Istanbul
2018-08-21
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/bal-ova

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Balçova.

How many clinical trials are recruiting in Balçova?

6 of the 14 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Balçova), 14 studies
PhaseStudiesRecruitingShare
Phase 39564.3%
Phase 1/23121.4%
Phase 2107.1%
Phase 2/3107.1%

Most active sponsors

Lead sponsors with the most studies (Balçova)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC32
BeOne Medicines22
Acerta Pharma BV10
Celgene10
Eli Lilly and Company10
EyeBiotech Ltd.10
Janssen Research & Development, LLC10
Loxo Oncology, Inc.11
Stemline Therapeutics, Inc.11
Stichting European Myeloma Network10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.